Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Cahill Represents Initial Purchaser in $500 Million Offering for Catalent Pharma Solutions, Inc.

Date: 06/27/19

Cahill represented the initial purchaser in connection with a Rule 144A offering of $500,000,000 aggregate principal amount of 5.00% senior notes due 2027 for Catalent Pharma Solutions, Inc., a company involved in technology and development for drugs, biologics and consumer health products. Proceeds from the offering were used to repay certain existing indebtedness and for general corporate purposes.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com